Martina Perešin Vranjković

Dr. Martina Perešin Vranjković


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2023 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
NANatasa Andrijasevic
Natasa Andrijasevic
MVMartina Perešin Vranjković
Martina Perešin Vranjković
KDKarolina Dobrović
Karolina Dobrović
NANatasa Andrijasevic
Natasa Andrijasevic
SASaša Andrašević
Saša Andrašević
ATArjana Tambic
Arjana Tambic
Right-sided infective endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA) is strongly associated with intravenous drug abuse, congenital heart disease, or previous medical treatment and is rare in healthy patients without a history of drug abuse. Here, we present a case of an 18-year-old male with no drug abuse history and no medical burden who was diagnosed with MRSA tricuspid valve endocarditis. Due to initial symptoms which indicated community-acquired pneumonia and radiological finding of interstitial lesions, empiric therapy with ceftriaxone and azithromycin was started. After the detection of Gram-positive cocci in clusters in several blood culture sets, endocarditis was suspected, and flucloxacillin was added to the initial therapy. As soon as methicillin resistance was detected, the treatment was switched to vancomycin. Transesophageal echocardiography established the diagnosis of right-sided infective endocarditis. A toxicological analysis of hair was carried out, and no presence of narcotic drugs was found. After six weeks of therapy, the patient was fully recovered. Exceptionally, tricuspid valve endocarditis can be diagnosed in previously healthy people who are not drug addicts. As the clinical presentation commonly resembles a respiratory infection, a misdiagnosis is possible. Although MRSA rarely causes community-acquired infections in Europe, clinicians should be aware of this possibility.

26 September 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
MVMartina Perešin Vranjković
Martina Perešin Vranjković
AHAnaMarija Vitko Havliček
AnaMarija Vitko Havliček
MKMartina Kramar
Martina Kramar
MTMirjana Balen Topić
Mirjana Balen Topić
DBDavid Beck
David Beck
Relja BeckRelja Beck
Relja Beck
We report the first confirmed case of persistent microfilaremia in a human host infected with Dirofilaria repens. A 54-year-old woman from an endemic area in Croatia presented with peripheral eosinophilia and dermatological symptoms. Over four months, microfilariae were repeatedly detected in her blood using thick smears and Knott’s test, and the diagnosis was molecularly confirmed via COI gene sequencing and detection of Wolbachia endosymbionts. This case provides compelling evidence that D. repens can sustain a complete or near-complete life cycle in humans under specific conditions. Our findings have significant implications for clinical diagnostics, One Health surveillance, and public health interventions.